Company intelligence / Profile preview
Tibet Aim Pharm
Beijing, Beijing, Chinaemyy.cn ↗
- Ownership
- Private
- Development stage
- Commercial
01
Overview
Tibet Aim Pharm is a publicly listed pharmaceutical company in China with a broad portfolio of marketed drugs including small molecules and traditional Chinese medicines. Its product line covers metabolic diseases (diabetes), cardiovascular conditions, women’s health/obstetrics, gastroenterology/digestive health, pain/inflammation management as well as emergency antidotes for poisoning. The company is active in R&D but specific late-stage pipeline assets are not detailed in public sources.
- Therapeutic areas
- EndocrinologyOtherGastroenterologyCardiovascularWomen's Health
- Modalities
- Small moleculesPeptides/hormonesTraditional Chinese medicine formulations
- Industry
- Biotech
02
Drug pipeline
2 assets1 more asset in the full pipeline.
Beyond the preview
Go deeper on Tibet Aim Pharm.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Tibet Aim Pharm.